4
Tetrahedron Letters
11.
Kouznetsov, V. V. Tetrahedron 2009, 65, 2721-2750.
14.5 Hz, 9.0 Hz, 2.0 Hz, 1H), 1.66 (ddd, J = 15.5 Hz, 9.0
Hz, 1.5 Hz, 1H); m/z = 377.84 [M+H]+. Compound 12: 1H
NMR (500 MHz, DMSO-d6) 7.69 (brs, 1H), 7.66 (dd as
t, J = 1.5 Hz, 1H), 7.42 (d, J = 1.5 Hz, 1H), 7.32 (dd, J =
8.5 Hz, 2.0 Hz, 1H), 6.95 (s, 2H), 6.77 (d, J = 8.5 Hz, 1H),
6.59 (d, J = 1.5 Hz, 1H), 6.20 (s, 1H), 5.88 – 5.82 (m,1H),
5.67 – 5.63 (m, 1H), 4.51 (d, J = 2.0 Hz, 1H), 4.04 (d, J =
9.0 Hz, 1H), 2.99 (dq, J = 8.5 Hz, 3.5 Hz, 1H), 2.38 (ddd, J
= 16.5 Hz, 9.5 Hz, 2.5 Hz, 1H), 1.98 (dd, J = 16 Hz, 9 Hz,
1H); m/z = 317.64 [M+H]+ . Compound 13: 1H NMR (500
MHz, CDCl3) 8.12 (d, J = 8.5 Hz, 1H), 7.90 (dd, J = 7.0
Hz, 2.0 Hz, 1H), 7.82 (d, J = 7.0 Hz, 1H), 7.80 (d, J = 9.0
Hz, 1H), 7.57 – 7.46 (m, 3H), 6.72 (s, 1H), 6.64 (d, J = 1.5
Hz, 2H), 5.86 – 5.79 (m, 1H), 5.68 – 5.60 (m, 1H), 5.35 (d,
J = 3.0 Hz, 1H), 4.25 – 4.18 (m, 1H), 3.78 (s, 3H), 3.54 (s,
1H), 3.30 (dq, J = 9.0 Hz, 2.5 Hz, 1H), 2.66 (qdd, J = 17.0
Hz, 9.0 Hz, 2.5 Hz, 1H), 1.64 (tdd, J = 16.5 Hz, 9.0 Hz, 2.0
12.
Smith, C. D.; Gavrilyuk, J. I.; Lough, A. J.; Batey, R. A. J.
Org. Chem. 2010, 75, 702-715.
Michael, J. P. Natural Product Reports 2008, 25, 166-187.
Glushkov, V. A.; Tolstikov, A. G. Russ. Chem. Rev. 2008,
77, 137-159.
Krueger, A. C.; Malachowski, W. P. In Encyclopedia of
Reagents for Organic Synthesis: Wiley Online Library,
2008.
Povarov, L. S. Russ. Chem. Rev. 1967, 36, 656-670.
Grieco, P. A.; Bahsas, A. Tetrahedron Lett. 1988, 29,
5855-5858.
Kiselyov, A. S.; Smith, L.; Armstrong, R. W. Tetrahedron
1998, 54, 5089-5096.
Babu, G.; Perumal, P. T. Tetrahedron 1998, 54, 1627-
1638.
Nagarajan, R.; Chitra, S.; Perumal, P. T. Tetrahedron
2001, 57, 3419-3423.
13.
14.
15.
16.
17.
18.
19.
20.
21.
22.
23.
24.
25.
Hz, 1H); m/z = 328.36 [M+H]+. Compound 14: H NMR
1
Nagarajan, R.; Perumal, P. T. Synth. Commun. 2001, 31,
1733-1736.
Nagarajan, R.; Magesh, C. J.; Perumal, P. T. Synthesis
2004, 69-74.
Kumar, R. S.; Nagarajan, R.; Perumal, P. T. Synthesis
2004, 949-959.
Kappe, C. O.; Dallinger, D. Nat. Rev. Drug Disc. 2006, 5,
51-63.
Astudillo, L. S.; Gutierrez, M.; Gaete, H.; Kouznetsov, V.
V.; Melendez, C. M.; Palenzuela, J. A.; Vallejos, G. Lett.
Org. Chem. 2009, 6, 208-212.
Xing, X. L.; Wu, J. L.; Dai, W. M. Tetrahedron 2006, 62,
11200-11206.
Duvelleroy, D.; Perrio, U.; Parisel, O.; Lasne, M. C. Org.
& Biomol. Chem. 2005, 3, 3794-3804.
Singh, M. S.; Raghuvanshi, K. Tetrahedron 2012, 68,
8683-8697.
(500 MHz, CDCl3) 8.10 (d, J = 8.0 Hz, 1H), 7.90 (dd, J =
8.0 Hz, 2.0 Hz, 1H) 7.81 (d, J = 8.0 Hz, 1H), 7.77 (d, J =
6.5 Hz, 1H), 7.58 – 7.48 (m, 3H), 7.23 (dd, J = 2.5 Hz, 1.0
Hz, 1H), 7.10 (dd, J = 8.5 Hz, 2.5 Hz, 1H), 5.82 – 5.79 (m,
1H), 5.68 – 5.62 (m, 1H), 5.40 (d, J = 3.0 Hz, 1H), 4.20 (d,
J = 9.0 Hz, 1H), 3.75 (s, 1H), 3.30 (dq, J = 8.5 Hz, 3.0 Hz,
1H), 2.62 (qdd, J = 17.0 Hz, 9.5 Hz, 2.5 Hz, 1H), 1.64
(qdd, J = 16.0 Hz, 8.5 Hz, 1.5 Hz, 1H); m/z = 377.16
[M+H]+. Compound 15: H NMR (500 MHz, DMSO-d6)
1
7.51 (d, J = 1.5 Hz, 1H), 7.32 (dd, J = 8.5 Hz, 2.0 Hz,
1H), 6.91 (s, 2H), 6.61 (d, J = 8.5 Hz, 1H), 6.31 (d, J = 1.5
Hz, 1H), 5.82 - 5.76 (m, 1H), 5.74 - 5.68 (m, 1H), 3.82 (s,
1H), 3.12 - 3.02 (m, 1H), 2.70 - 2.54 (m, 3H), 2.09 (dd, J =
9.0 Hz, 2.0 Hz, 1H); m/z = 250.99 [M+H]+. Compound 16:
1H NMR (500 MHz, DMSO-d6) 12.21 (s, 1H), 7.66 (s,
1H), 7.65 (d, J = 10.0 Hz, 1H), 7.52 (dt, J = 8.0 Hz, 2.0
Hz, 2H), 6.75 (d, J = 8.5 Hz, 2.0 Hz, 1H), 6.39 (s, 1H),
5.98 - 5.90 (m, 1H), 5.64 - 5.56 (m, 1H), 4.89 (d, J = 2.5
Hz, 1H), 4.08 (d, J = 8.5 Hz, 1H), 3.06 (ddq, J = 8.5 Hz,
3.5 Hz, 1.5 Hz, 1H), 2.36 (ddd, J = 15.5 Hz, 10.0 Hz, 2.0
Hz, 1H), 1.61 (dd, J = 15.0 Hz, 9.0 Hz, 1H); m/z = 361.23
[M+H]+.
26.
27.
28.
29.
30.
Auge, J.; Lubin-Germain, N.; Uziel, J. Synthesis 2007,
1739-1764.
Experimental procedure for the synthesis of TQS (3) : In a
microwave vial, cyclopentadiene (254 mg, 3.84 mmol, 3
equiv.) was added to a suspension of 1–naphthaldehyde
(200 mg, 1.28 mmol), 4-aminosulfonamide (220 mg, 1.28
mmol) and indium (III) chloride (55.6 mg, 0.256 mmol,
0.2 equiv.) in acetonitrile (5 mL). The reaction vial was
placed in a Biotage Initiator microwave synthesizer and
heated to 100°C for 15 min. The contents were added to
10% aqueous Na2CO3 solution (0.1 M; 10 mL) and
extracted with chloroform (3×20 mL). The combined
organic layer was washed with brine (15 mL), dried
(Na2SO4) and concentrated under reduced pressure. The
residue was treated with hexane/dichloromethane to
precipitate out compound 3 as an off white solid (290 mg;
yield 60%).7 Compounds 7, 8, 10, 11, 13, and 14 were
purified by column chromatography (EtOAc/Hexane =
10/90 50/50) to yield the desired product. The rest were
crystallized from dichloromethane/hexane. All compounds
were >95% pure by HPLC and 1H NMR.
Compound 9: 1H NMR (500 MHz, DMSO-d6) 7.34 (d, J
= 2.0 Hz, 1H), 7.26 (dd, J = 8.5 Hz, 2.0 Hz, 1H), 6.89 (s,
2H), 6.80 (d, J = 9.0 Hz, 1H), 5.87 – 5.81 (m, 1H), 5.70 –
5.65 (m, 1H), 5.62 (s, 1H), 3.89 (d, J = 9.0 Hz, 1H), 3.02
(dd, J = 8.5 Hz, 2.0 Hz, 1H), 2.33 – 2.23 (m, 1H), 2.22 –
2,14 (m,2H), 1.88 – 1.60 (m, 4H), 1.34 – 1.10 (m , 4H),
1.16 – 0.88 (m, 2H); m/z = 333.79 [M+H]+. Compound
10: 1H NMR (500 MHz, CDCl3) d J = 8.0 Hz, 1H),
7.90 (dd, J = 7.5 Hz, 1.5 Hz, 1H), 7.80 (d, J = 7.5 Hz, 1H),
7.74 (d, J = 7.5 Hz, 1H), 7.64 (d, J = 8.0 Hz, 1H), 7.57 –
7.44 (m, 3H), 7.27 (d, J = 7.5 Hz, 1H), 6.78 (t, J = 7.5 Hz,
1H), 5.99 (s, 1H), 5.84 – 5.79 (m, 1H), 5.65 – 5.59 (m,
1H), 5.52 (d, J = 3.0 Hz, 1H), 4.90 (s, 2H), 4.28 (d, J = 9.0
Hz, 1H), 3.33 (dq, J = 9.0 Hz, 2.0 Hz, 1H), 2.56 (ddd, J =